U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C4H6O
Molecular Weight 70.0898
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3,4-EPOXY-1-BUTENE

SMILES

C=CC1CO1

InChI

InChIKey=GXBYFVGCMPJVJX-UHFFFAOYSA-N
InChI=1S/C4H6O/c1-2-4-3-5-4/h2,4H,1,3H2

HIDE SMILES / InChI

Molecular Formula C4H6O
Molecular Weight 70.0898
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

PubMed

PubMed

TitleDatePubMed
Reactive metabolites of 1,3-butadiene: DNA and hemoglobin adduct formation and potential roles in carcinogenicity.
2001
Synthesis and characterization of oligodeoxynucleotides containing an N1 beta-hydroxyalkyl adduct of 2'-deoxyinosine.
2001 Jun
In vitro genotoxicity testing of (1-chloroethenyl)oxirane, a metabolite of beta-chloroprene.
2001 Jun 1
A novel DNA adduct, originating from 1,2-epoxy-3,4-butanediol, is the major DNA adduct after exposure to [2,3-(14)C]-1,3-butadiene,[4-(14)C]-1,2-epoxy-3-butane.
2001 Jun 1
Advances in the mass spectrometry of hemoglobin adducts: global analysis of the covalent binding of butadiene monoxide.
2001 Jun 1
Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
2001 Jun 1
Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessment.
2001 Jun 1
Physiological modeling of butadiene disposition in mice and rats.
2001 Jun 1
First-pass metabolism of 1,3-butadiene in once-through perfused livers of rats and mice.
2001 Jun 1
Dose-dependent excretion of unconjugated 3-butene-1,2-diol measured in urine with a gc/ms after 1,3-butadiene exposure.
2002
Mutagenic spectrum of butadiene-derived N1-deoxyinosine adducts and N6,N6-deoxyadenosine intrastrand cross-links in mammalian cells.
2002 Dec
Identification and characterization of a series of nucleoside adducts formed by the reaction of 2'-deoxyguanosine and 1,2,3,4-diepoxybutane under physiological conditions.
2003 Dec
Genetic susceptibility, biomarker respones, and cancer.
2003 Nov
Regio- and stereoselectivity of the addition of O-, S-, N-, and C-nucleophiles to the beta vinyl oxirane derived from D-glucal.
2004 Dec 10
DNA adducts in rats and mice following exposure to [4-14C]-1,2-epoxy-3-butene and to [2,3-14C]-1,3-butadiene.
2004 Jun 30
Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
2004 Mar 15
Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
2004 Mar 15
Characterization of alkyl-cobalamins formed on trapping of epoxide metabolites of 1,3-butadiene.
2004 May
Effects of 1,3-butadiene, isoprene, and their photochemical degradation products on human lung cells.
2004 Nov
Synthesis of chiral phosphoantigens and their activity in gamma delta T cell stimulation.
2004 Sep 6
Hemoglobin adducts and micronuclei in rodents after treatment with isoprene monoxide or butadiene monoxide.
2005 Aug 1
Structure of an oligodeoxynucleotide containing a butadiene oxide-derived N1 beta-hydroxyalkyl deoxyinosine adduct in the human N-ras codon 61 sequence.
2005 Mar 8
Palladium-catalyzed DYKAT of butadiene monoepoxide: enantioselective total synthesis of (+)-DMDP, (-)-bulgecinine, and (+)-broussonetine G.
2006 Aug 25
Copper-catalyzed rearrangement of vinyl oxiranes.
2006 Dec 20
Cellular analysis of disorazole C and structure-activity relationship of analogs of the natural product.
2006 Jan
3,4-Epoxy-1-butene, a reactive metabolite of 1,3-butadiene, induces somatic mutations in Xpc-null mice.
2006 Jan
Identification of covalent modifications in P450 2E1 by 1,2-epoxy-3-butene in vitro.
2007 Mar 20
N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides.
2007 Mar 20
Quantitative analysis of N-terminal valine peptide adducts specific for 1,2-epoxy-3-butene.
2007 Mar 20
Mutagenicity of stereochemical configurations of 1,2-epoxybutene and 1,2:3,4-diepoxybutane in human lymphblastoid cells.
2007 Mar 20
Synthesis of DNA oligodeoxynucleotides containing structurally defined N6-(2-hydroxy-3-buten-1-yl)-adenine adducts of 3,4-epoxy-1-butene.
2007 Mar 20
Some insights into the mode of action of butadiene by examining the genotoxicity of its metabolites.
2007 Mar 20
Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats.
2007 Mar 20
Development of a physiologically based toxicokinetic model for butadiene and four major metabolites in humans: global sensitivity analysis for experimental design issues.
2007 May 1
Catalytic performance of symmetrical and unsymmetrical sulfur-containing pincer complexes: synthesis and tandem catalytic activity of the first PCS-pincer palladium complex.
2008
Bimetallic dendrimer-encapsulated nanoparticles as catalysts: a review of the research advances.
2008 Aug
HPRT mutations in lymphocytes from 1,3-butadiene-exposed workers in China.
2008 Feb
Evaluation of cancer tests of 1,3-butadiene using internal dose, genotoxic potency, and a multiplicative risk model.
2008 Oct 1
Genotoxicity of 1,3-butadiene and its epoxy intermediates.
2009 Aug
An efficient and general enantioselective synthesis of sphingosine, phythosphingosine, and 4-substituted derivatives.
2009 Jan 1
Investigation on the mechanisms of genotoxicity of butadiene, styrene and their combination in human lymphocytes using the Comet assay.
2009 May 12
Stereoselective ring expansion of vinyl oxiranes: mechanistic insights and natural product total synthesis.
2010 Feb 22
Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
2010 Jun
Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene.
2010 Jun
Quantitative investigation on the metabolism of 1,3-butadiene and of its oxidized metabolites in once-through perfused livers of mice and rats.
2010 Mar
1,3-Butadiene: II. Genotoxicity profile.
2010 Oct
Inhibitory potency of 4-carbon alkanes and alkenes toward CYP2E1 activity.
2014 Apr 6
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:35:53 GMT 2023
Edited
by admin
on Sat Dec 16 08:35:53 GMT 2023
Record UNII
478ERR5NKR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3,4-EPOXY-1-BUTENE
HSDB  
Systematic Name English
OXIRANE, 2-ETHENYL-
Systematic Name English
3,4-EPOXY-1-BUTENE [HSDB]
Common Name English
OXIRANE, ETHENYL-
Systematic Name English
VINYL EPOXIDE
Common Name English
NSC-8023
Code English
EPOXYBUTADIENE
Systematic Name English
1,3-BUTADIENE MONOEPOXIDE
Common Name English
VINYLOXIRANE
Systematic Name English
(±)-VINYLOXIRANE
Systematic Name English
2-VINYLOXIRANE
Systematic Name English
1,2-OXIDO-3-BUTENE
Common Name English
1,2-EPOXY-3-BUTENE
Systematic Name English
1-BUTENE, 3,4-EPOXY-
Systematic Name English
NSC-24251
Code English
BUTADIENE EPOXIDE
Common Name English
BUTADIENE MONOXIDE
Systematic Name English
1,3-BUTADIENE MONOOXIDE
Systematic Name English
Code System Code Type Description
PUBCHEM
13586
Created by admin on Sat Dec 16 08:35:53 GMT 2023 , Edited by admin on Sat Dec 16 08:35:53 GMT 2023
PRIMARY
HSDB
5520
Created by admin on Sat Dec 16 08:35:53 GMT 2023 , Edited by admin on Sat Dec 16 08:35:53 GMT 2023
PRIMARY
FDA UNII
478ERR5NKR
Created by admin on Sat Dec 16 08:35:53 GMT 2023 , Edited by admin on Sat Dec 16 08:35:53 GMT 2023
PRIMARY
NSC
8023
Created by admin on Sat Dec 16 08:35:53 GMT 2023 , Edited by admin on Sat Dec 16 08:35:53 GMT 2023
PRIMARY
EPA CompTox
DTXSID4025240
Created by admin on Sat Dec 16 08:35:53 GMT 2023 , Edited by admin on Sat Dec 16 08:35:53 GMT 2023
PRIMARY
NSC
24251
Created by admin on Sat Dec 16 08:35:53 GMT 2023 , Edited by admin on Sat Dec 16 08:35:53 GMT 2023
PRIMARY
ECHA (EC/EINECS)
213-210-4
Created by admin on Sat Dec 16 08:35:53 GMT 2023 , Edited by admin on Sat Dec 16 08:35:53 GMT 2023
PRIMARY
CAS
930-22-3
Created by admin on Sat Dec 16 08:35:53 GMT 2023 , Edited by admin on Sat Dec 16 08:35:53 GMT 2023
PRIMARY